Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Compass Therapeutics ( (CMPX) ) just unveiled an update.
Compass Therapeutics has appointed Barry Shin as Chief Financial Officer, bringing over two decades of experience in finance and the biopharmaceutical industry. With past roles at Trevena, Inc. and investment banking firms, Shin’s expertise is expected to advance Compass’s clinical and pre-clinical assets, including the promising CTX-009. His appointment comes as the company anticipates key catalysts in 2025, aiming to deliver value to shareholders.
Learn more about CMPX stock on TipRanks’ Stock Analysis page.